CMV (Cytomegalovirus) is Life Threatening to Babies; polyDNA Recommends Targeting the Latent CMV With Gene-Eden-VIR

An article published on the website of the NBC affiliate news website, ketknbc.com on March 1, 2014 said that the Cytomegalovirus killed the baby of a family from Houston, Texas (1).” polyDNA recommends that women speak to their doctors about Gene-Eden-VIR when planning a pregnancy.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
We recommend targeting the latent CMV prior to getting pregnant. Before a woman attempts to conceive, she should speak with her doctor about taking Gene-Eden-VIR. - Mike Evans, polyDNA

Rochester, NY (PRWEB) March 14, 2014

The cytomegalovirus (CMV) can kill babies. Now, a family whose baby died from a CMV infection is raising awareness about the virus. “The family spoke about the little known virus that took the life of their newborn baby and why everyone should know about CMV. ‘It wasn't until literally the day before we had her that we had any signs at all,’ said father, Patrick Armstrong. Just 12 days after being born, baby Maddie passed away (1).” polyDNA recommends that parents planning a pregnancy should speak to their doctors about Gene-Eden-VIR. This natural antiviral targets the latent CMV, and was recently proven to reduce symptoms of a CMV infection in a post-marketing clinical study that followed FDA guidelines.

“For pregnant women, the most common exposures to CMV are through contact with the saliva and urine of young children or through sexual contact. Young children can transmit CMV for months after they first become infected. However, CMV does not spread easily. One in 5 parents of children who have active CMV infections become infected with CMV over the course of a year.” (See the CDC’s website, last updated on June 24, 2013) (2).

“In the United States, more than 5,000 children suffer illness and permanent disabilities caused by congenital CMV infection every year, although many infants – about 80 out of 100 – with congenital CMV infection never develop symptoms or disabilities from the infection. Children with congenital CMV infection are more likely to have permanent disabilities if they had symptoms of CMV infection at birth. However, some children with congenital CMV infection who appear healthy at birth can develop hearing or vision loss over time (2).” Additionally, young babies can succumb to the virus and die.

For many years, it was thought that children born to mothers with an active CMV infection were at the highest risk of being born with symptomatic CMV disease. However, recent studies have shown that even when the mother has a latent CMV infection, the risk to the newborn is the same. Researchers wrote that “symptomatic infection occurs with similar frequency in children born to women with primary CMV infection and those born to women who were CMV seroimmune (that is, the mother has a latent CMV infection) before pregnancy. In addition, the severity of newborn disease and the rates of CMV-associated SNHL also do not differ between primary and nonprimary (latent) infection groups.” (See Clinical Infectious Diseases, from December 2013) (3).

What can parents do to reduce the risk of CMV infection?

There are some drugs approved for use against a CMV infection. However, most of these are used exclusively in immunocompromised individuals (such as those with HIV). In healthy people these drugs are “limited by their toxicity, poor oral bioavailability, modest
efficacy, and the development of drug resistance.” (See Pharmacology & Pharmacy, from September 2013) (4).

There are also some natural remedies available. However, only Gene-Eden-VIR has undergone rigorous scientific testing. In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that Gene-Eden-VIR is safe and effective (4). Additionally, up to 70% of those studied reported a decrease in symptoms associated with EBV infection, and users experienced an increase in overall health (4).

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target latent viruses (4).

“We recommend targeting the latent CMV prior to getting pregnant. Before a woman attempts to conceive, she should speak with her doctor about taking Gene-Eden-VIR. As the study authors wrote, “Healthcare practitioners should recommend Gene-Eden-VIR as a safe and effective antiviral treatment.” Mike Evans, polyDNA

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com.

All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Texas family using their story to raise awareness of CMV. Published on March 1, 2014.
http://www.ketknbc.com/news/texas-family-using-their-story-to-raise-awareness

(2) CDC - Cytomegalovirus: Protect Your Baby. Last updated on June 24, 2013.
http://www.cdc.gov/features/cytomegalovirus/

(3) Congenital cytomegalovirus infection: clinical outcome. Published December 2013.
http://www.ncbi.nlm.nih.gov/pubmed/24257422

(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
         http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.